Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar details
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- General Virology
-
46 min
1. Principles of virology- Prof. Vincent Racaniello
-
36 min
2. The type I interferon system and viruses- Dr. Adolfo Garcia-Sastre
-
45 min
3. Immune responses to viruses- Prof. Paul Klenerman
- Emerging Pathogens
-
29 min
4. Emerging or newly discovered viral causes of acute lower respiratory tract infections worldwide- Dr. Marietjie Venter
- Mrs. Orienka Hellferscee
-
37 min
5. Emerging respiratory viruses - discoveries between 2001 and 2005- Prof. Ron Fouchier
-
28 min
6. Usage of vaccines and therapeutics in public health emergencies 1- Prof. Gary Kobinger
-
39 min
7. Usage of vaccines and therapeutics in public health emergencies 2- Prof. Gary Kobinger
-
50 min
8. Influenza virus pandemics: past and future- Prof. Peter Palese
-
63 min
9. SARS-CoV and other emerging coronaviruses- Prof. Ralph Baric
-
36 min
10. Dengue, Zika and Chickungunya viruses- Prof. Ana Fernandez-Sesma
-
43 min
11. Paramyxoviruses: biology & pathogenesis- Prof. Benhur Lee
-
36 min
12. Antiviral drugs (non-HIV)- Prof. Megan Shaw
-
41 min
13. Biodefense challenges- Dr. David Franz
- Important Pathogens and their Diseases
-
38 min
14. Natural history and pathogenesis of herpes virus infections- Prof. Richard Whitley
-
40 min
15. Cytomegalovirus biology- Prof. Domenico Tortorella
-
46 min
16. Hepatitis C virus: discovery, cure and protection- Dr. Matthew Evans
-
32 min
17. Fundamentals of HIV biology- Prof. Viviana Simon
-
44 min
18. Measles- Prof. Diane E. Griffin
-
42 min
19. Monkeypox virus, vaccines, and therapeutics- Prof. Rachel Roper
- New Frontiers
-
45 min
-
55 min
-
30 min
22. Viruses as anticancer weapons- Prof. Roberto Cattaneo
-
48 min
23. Novel approaches to diagnosis of viral infections- Prof. W. Ian Lipkin
-
36 min
24. The Global Virus Network: collaboration to address pandemic and regional threats- Prof. Sten H. Vermund
-
31 min
25. Elite controllers of HIV: from discovery to future therapies- Prof. Bruce Walker
- Archived Lectures *These may not cover the latest advances in the field
-
43 min
26. Principles of virology I- Prof. Richard Condit
-
43 min
27. Principles of virology II- Prof. Richard Condit
-
36 min
28. Complex DNA viruses: herpes virus- Dr. John Blaho
-
38 min
29. Adeno-associated viruses (AAV)- Prof. Kenneth Berns
-
60 min
30. Poxviruses: smallpox (variola), vaccinia and monkeypox- Prof. Paula Traktman
-
26 min
31. Can HPV testing be the sole primary cervical screening modality?- Prof. Jack Cuzick
-
29 min
32. From viruses to oncolytics- Prof. Roberto Cattaneo
-
38 min
33. Non HIV antivirals- Prof. Mary Klotman
-
42 min
34. Gastroenteritis viruses- Prof. Mary Estes
-
46 min
35. Biodefense challenges- Dr. Connie Schmaljohn
-
32 min
-
49 min
37. The past, present and future of vaccination- Prof. Stanley Plotkin
-
41 min
38. Filoviruses- Dr. Christopher Basler
-
41 min
39. Bunyaviruses- Prof. Richard Elliott
-
41 min
40. The immunobiology of HIV- Prof. Norman Letvin
-
59 min
41. Hepatitis C and HCV- Prof. Stanley Lemon
Printable Handouts
Navigable Slide Index
- Introduction
- Bioterrorism/biowarfare
- CDC priority list of pathogens
- Viruses as BW agents
- Effective viral biothreats
- Biodefense vaccines
- Viral biothreats
- Smallpox description
- Smallpox historical BW threat
- Smallpox eradication
- Smallpox: the disease
- Smallpox: pros as a biothreat
- Smallpox: cons as a biothreat
- CDC vaccination plan for a BT event
- Monkeypox
- Smallpox: live Vaccinia virus vaccines
- Smallpox: MVA (modified Vaccinia virus Ankara)
- Smallpox: vaccines - risk vs. benefit
- Smallpox: therapeutics - cidofovir
- Smallpox: therapeutics - ST-246
- Smallpox - BW/BT considerations
- Equine encephalitis viruses
- VEEV, EEEV, WEEV
- U.S. cases of EEE
- U.S. cases of WEE
- Natural EEEV and WEEV cycles
- Natural VEEV cycles
- VEE outbreaks
- Existing Alphavirus vaccines
- Next generation vaccines
- VEEV, EEEV, WEEV - BW/BT considerations
- Viral hemorrhagic fevers
- Virus families causing VHF
- Viral hemorrhagic fever distribution
- Symptoms of VHF
- Treatment of VHF
- Filoviruses
- VHF as BW agents: Marburg and Ebola viruses
- Filoviruse distribution
- Filoviruse mortality
- Ebola hemorrhagic fever
- Marburg hemorrhagic fever
- Ebola hemorrhagic fever - disease symptoms
- Treatment of filovirus infections
- Stopping a filovirus epidemic
- Filovirus vaccine development
- FHF - BW/BT considerations
- Rift Valley fever virus
- RVF historically exclusive in Africa
- RVF in Saudi Arabia/Yemen 2002
- Correlation of rainfall to outbreaks of RVFV
- RVF ongoing outbreak - Kenya
- RVF - human disease
- Treatment of RVFV
- RVF - animal disease
- Rift valley fever vaccines (1)
- Rift valley fever vaccines (2)
- Rift valley fever vaccines (3)
- Rift Valley fever virus - BW/BT considerations
- Other challenges
- Conclusions
Topics Covered
- Viruses as bioterrorism or biowarfare threats
- Smallpox virus and monkeypox virus
- Equine encephalitis viruses: Venezuelan, eastern and western equine encephalitis viruses
- Ebola and Marburg viruses
- Rift Valley fever virus
- Genetically engineered viruses
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Schmaljohn, C. (2007, October 1). Biodefense challenges [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/XERH2882.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Connie Schmaljohn has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
